Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix

Gynecologic Oncology

Volumn 95, Issue 3, 2004, Pages 646-654

  Silva Filho, Agnaldo L ^a,c   Traiman, Paulo ^a   Triginelli, Sérgio A ^b   Reis, Fernando M ^b   Pedrosa, Moises S ^b   Miranda, Dairton ^b   Abreu, Eliane S ^a   Macarenco, Ricardo S S ^a   Cunha Melo, José R ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c NONE   (Brazil)

Author keywords

Angiogenesis; Carcinoma; CD31; Cervix; Ki 67; MIB 1; p53

Indexed keywords

CD31 ANTIGEN; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BENIGN TUMOR; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADICAL HYSTERECTOMY; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; UTERINE CERVIX CARCINOMA; UTERUS MYOMA; VAGINAL HYSTERECTOMY;

ADULT; AGED; ANTIGENS, CD31; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS; VAGINA;

EID: 9944260473     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.07.059     Document Type: Article

References (36)

1. D.M. Parkin, P. Pisani, and J. Ferlay Global cancer statistics CA Cancer J. Clin. 49 1999 33 64
2. S.E. Waggoner Cervical cancer Lancet 361 2003 2217 2225
3. Ministério da Saúde, 2003. Estimativa de incidência e mortalidade por câncer no Brasil [INCA web site]. Available at: www.inca.gov.br.. Accessed October 10, 2003.
4. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
5. A. Ferenczy, and E. Franco Persistent human papillomavirus infection and cervical neoplasia Lancet Oncol. 3 2002 11 16
6. P.S. Araujo Souza, and L.L. Villa Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil Mutat. Res. 544 2003 375 383
7. W.A. Tjalma, J.J. Weyler, J.J. Bogers, C. Pollefliet, M. Baay, and C.G. Goovaerts The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer Eur. J. Obstet. Gynecol. Reprod. Biol. 97 2001 223 230
8. M.A. Stanley Human papillomavirus and cervical carcinogenesis Best Pract. Res. Clin. Obstet. Gynaecol. 15 2001 663 676
9. W.C. Hahn, and R.A. Weinberg Rules for making human tumor cells N. Engl. J. Med. 347 2002 1593 1603
10. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
11. G.G. Garzetti, A. Ciavattini, G. Lucarini, G. Goteri, M. De Nictolis, and G. Biagini Immunostaining in cervical carcinoma of young patients Gynecol. Oncol. 67 1997 184 187
12. G. Sauer, and H. Deissler Angiogenesis: prognostic and therapeutic implications in gynecologic and breast malignancies Curr. Opin. Obstet. Gynecol. 15 2003 45 49
13. J. Folkman What is the evidence that tumors are angiogenesis dependent J. Natl. Cancer Inst. 82 1990 4 6
14. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
15. A. Dellas, H. Moch, E. Schultheiss, G. Feichter, A.C. Almendral, and F. Gudat Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations Gynecol. Oncol. 67 1997 27 33
16. ACOG Practice Bulletin Diagnosis and treatment of cervical carcinomas Am. J. Obstet. Gynecol. 99 2002 855 867
17. E.R. Estape, R. Angioli, M. Madrigal, M. Janicek, C. Gomez, and M. Penalver Close vaginal margins as a prognostic factor after radical hysterectomy Gynecol. Oncol. 68 1998 229 232
18. T. Ijaz, P.J. Eifel, T. Burke, and M.J. Oswald Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma Gynecol. Oncol. 70 1998 241 246
19. T.W. Burke, W.J. Hoskins, P.B. Heller, M.C. Shen, E.B. Weiser, and R.C. Park Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma Obstet. Gynecol. 69 1987 382 385
20. H.B. Krebs, B.F. Helmkamp, B.U. Sevin, S.R. Poliakoff, M. Nadji, and H.E. Averette Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection Obstet. Gynecol. 59 1982 422 427
21. D.M. Larson, L.J. Copeland, C.A. Stringer, D.M. Gershenson, J.M. Malone, and C.L. Edwards Recurrent cervical carcinoma after radical hysterectomy Gynecol. Oncol. 30 1988 381 387
22. M.E. Potter, R.D. Alvarez, F.L. Gay, H.M. Shingleton, S.J. Soong, and K.D. Hatch Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer Gynecol. Oncol. 37 1990 74 77
23. J.H. Shepherd Cervical and vulva cancer: changes in FIGO definitions of staging Br. J. Obstet. Gynaecol. 103 1996 405 406
24. N.S. Heaney A report of 565 vaginal hysterectomies performed for benign pelvic disease Am. J. Obstet. Gynecol. 28 1934 751
25. T. Kamura, T. Shigematsu, and T. Kaku Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy Acta Obstet. Gynecol. Scand. 78 1999 452 477
26. S.M. Hsu, L. Raine, and H. Fanger Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled (PAP) procedures J. Histochem. Cytochem. 29 1981 577 580
27. D.P. Lane p53, Guardian of the genome Nature 358 1992 15 16
28. A.L. Borresen, A. Helland, J. Nesland, R. Holm, C. Trope, and J. Kaern Papillomavirus, p53, and cervical cancer Lancet 339 19923 1350 1351
29. H.A. Lambkin, C.M. Mothersill, and P. Kelehan Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection J. Pathol. 172 1994 13 18
30. D.J. Dabbs Diagnostic immunohistochemistry 2002 Churchill Livingstone Philadelphia
31. Y. Koyamatsu, M. Yokoyama, Y. Nakao, K. Fukuda, T. Saito, and K. Matsukuma A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas Gynecol. Oncol. 90 2003 547 551
32. G.G. Garzetti, A. Ciavattini, G. Lucarini, G. Goteri, M. de Nictolis, and M. Muzzioli MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity Gynecol. Oncol. 58 1995 28 33
33. S.P. Dobbs, L.J.R. Brown, and D. Ireland Platelet-derived endothelial cell growth factor expression and angiogenesis in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix Ann. Diagn. Pathol. 4 2000 286 292
34. A. Obermair, C. Wanner, and S. Bilgi Tumour angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival Am. J. Obstet. Gynecol. 178 1998 314 319
35. M.S. Piver, F.N. Rutledge, and P.J. Smith Five classes of extended hysterectomy of women with cervical cancer Obstet. Gynecol. 44 1974 265 267
36. N.R. Abu-Rustum, and W.J. Hoskins Radical abdominal hysterectomy Surg. Clin. North Am. 81 2001 815 828